Genus Lifesciences

What Genus Lifesciences does

Genus Lifesciences is a privately held pharmaceutical manufacturer headquartered in Allentown, Pennsylvania. Founded in 1999, the company produces both branded and generic pharmaceutical products. With 51-100 employees, Genus Lifesciences operates as a small-to-mid-sized participant in the U.S. pharmaceutical manufacturing sector.

The company's core business activity is pharmaceutical manufacturing—producing both proprietary branded formulations and generic equivalents. As a manufacturer, Genus Lifesciences operates in a heavily regulated industry requiring FDA compliance, cGMP manufacturing standards, and likely DEA registration for controlled substances. The 25-year operating history suggests an established production infrastructure and accumulated regulatory experience, though the specific product portfolio, therapeutic areas served, and manufacturing capabilities (solid oral dose, injectables, topicals, etc.) are not documented in the available data.

The business model is consistent with traditional pharmaceutical manufacturing revenue mechanics: generating revenue through product sales to wholesalers, distributors, pharmacy chains, and potentially institutional buyers. The company maintains a website at genuslifesciences.com, though it was inaccessible during data collection due to CAPTCHA protection. No information on pricing models, specific customer segments, distribution channels, partnerships, product launches, mergers and acquisitions, leadership changes, or funding rounds was available, limiting deeper analysis of the company's commercial mechanics and capital structure.

Name

Genus Lifesciences

Website

https://genuslifesciences.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Genus Lifesciences is a privately held pharmaceutical manufacturer founded in 1999 and based in Allentown, Pennsylvania. The company produces branded and generic pharmaceutical products, serving the U.S. healthcare market through pharmaceutical distribution channels.

Ownership category

akta.pro rank

Headquarters

HQ city

Allentown

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D

Core offering

Genus Lifesciences is a pharmaceutical manufacturer that develops, produces, and markets both branded and generic drug products. The company operates a manufacturing base in Allentown, Pennsylvania, supplying therapeutic pharmaceutical formulations to the U.S. healthcare market through standard pharmaceutical distribution channels.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic pharmaceutical products Off-patent, therapeutically equivalent generic drug formulations manufactured by Genus Lifesciences for sale to wholesalers, distributors, pharmacies, and healthcare providers in the United States.
• Branded pharmaceutical products Proprietary branded drug formulations developed and manufactured by Genus Lifesciences for sale to wholesalers, distributors, pharmacies, and healthcare providers in the United States.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Lannett Company: Lannett is a US-based manufacturer of generic pharmaceuticals with a comparable mid-sized footprint and a similar focus on off-patent solid oral and specialty generic formulations. It is one of the most directly comparable peers to Genus Lifesciences in terms of business model, customer base (wholesalers and distributors), and revenue scale.
• Amneal Pharmaceuticals: Amneal is a US-headquartered manufacturer of both generic and branded specialty pharmaceuticals, operating a hybrid model closely aligned to Genus's stated branded-generic strategy. It serves similar pharmacy, hospital, and institutional customers and competes across overlapping therapeutic categories.
• Apotex: Apotex is a Canadian-headquartered generic pharmaceutical manufacturer with a global footprint and US operations, producing generic formulations across a wide therapeutic range. It is comparable to Genus in product mix and customer segments.
• Zydus Pharmaceuticals (Cadila): Zydus is the US arm of Cadila Healthcare, manufacturing and marketing generic and specialty branded pharmaceuticals in the US. Its hybrid generic-branded model, manufacturing base, and distribution to US wholesalers make it a direct peer for Genus.

Broad incumbents

• Endo International: Endo is a larger specialty pharmaceutical manufacturer with a meaningful generics business alongside branded specialty assets. While broader and more diversified than Genus, it competes in overlapping therapeutic categories and serves the same institutional and retail channels.
• Mallinckrodt Pharmaceuticals: Mallinckrodt is a specialty pharmaceutical manufacturer with branded and generic product lines serving hospitals, clinics, and specialty pharmacies. Its hybrid branded-generic model and institutional customer overlap make it a relevant incumbent comparator for Genus.
• Teva Pharmaceutical Industries: Teva is the world's largest generic drug manufacturer with a substantial specialty branded franchise. As the dominant incumbent in the generic space, it sets the competitive baseline for pricing, distribution scale, and customer relationships against which Genus must compete.
• Sandoz (Novartis division): Sandoz is a global leader in generic pharmaceuticals and biosimilars, recently spun out from Novartis. It competes directly with Genus in the generic space and represents the scale ceiling that mid-sized players must either match via specialization or partner with via distribution agreements.
• Aurobindo Pharma: Aurobindo is one of the largest Indian-headquartered generic pharmaceutical manufacturers with a major US generics business. While significantly larger than Genus, it is a relevant incumbent comparator given its broad generic portfolio, US distribution scale, and active ANDA pipeline.

Regional players

• Glenmark Pharmaceuticals: Glenmark is an India-headquartered generic and specialty pharmaceutical manufacturer with significant US business, competing across respiratory, dermatology, and other therapeutic categories. It serves the same US customer base as Genus via its US subsidiary.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/genus-lifesciences-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genus Lifesciences